(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Voyager Therapeutics, Inc. Insider Trading
* In original currency USD
Loading Data
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Tuesday, June 3rd, 2025 | Vitale Nancy | director | 24,000 | A-Award | A | 24,000 | 3.28 USD | 78,720 USD |
| Tuesday, June 3rd, 2025 | SCANGOS GEORGE A | director | 24,000 | A-Award | A | 24,000 | 3.28 USD | 78,720 USD |
| Tuesday, June 3rd, 2025 | PIERCE GLENN | director | 24,000 | A-Award | A | 24,000 | 3.28 USD | 78,720 USD |
| Tuesday, June 3rd, 2025 | Onyia Jude | director | 24,000 | A-Award | A | 24,000 | 3.28 USD | 78,720 USD |
| Tuesday, June 3rd, 2025 | MACKEY CATHERINE J | director | 24,000 | A-Award | A | 24,000 | 3.28 USD | 78,720 USD |
| Tuesday, June 3rd, 2025 | Hyman Steven | director | 24,000 | A-Award | A | 24,000 | 3.28 USD | 78,720 USD |
| Tuesday, June 3rd, 2025 | Higgins Michael J | director | 24,000 | A-Award | A | 24,000 | 3.28 USD | 78,720 USD |
| Tuesday, June 3rd, 2025 | GERAGHTY JAMES A | director | 24,000 | A-Award | A | 24,000 | 3.28 USD | 78,720 USD |
| Tuesday, June 3rd, 2025 | Colon Grace | director | 24,000 | A-Award | A | 24,000 | 3.28 USD | 78,720 USD |
| Wednesday, April 2nd, 2025 | Ferguson Toby | officer: Chief Medical Officer | 157,914 | S-Sale | D | 10,086 | 3.43 USD | 34,595 USD |
| Wednesday, April 2nd, 2025 | Sandrock Alfred | director, officer: President and CEO | 430,931 | S-Sale | D | 10,885 | 3.43 USD | 37,336 USD |
| Friday, February 21st, 2025 | Carter Todd Alfred | officer: Chief Scientific Officer | 123,718 | A-Award | A | 46,000 | 0.00 USD | 0 USD |
| Friday, February 21st, 2025 | Carter Todd Alfred | officer: Chief Scientific Officer | 92,000 | A-Award | A | 92,000 | 4.22 USD | 388,240 USD |
| Thursday, February 20th, 2025 | Carter Todd Alfred | officer: Chief Scientific Officer | 77,718 | S-Sale | D | 3,305 | 4.26 USD | 14,079 USD |
| Friday, February 21st, 2025 | Sandrock Alfred | director, officer: President and CEO | 441,816 | A-Award | A | 145,000 | 0.00 USD | 0 USD |
| Thursday, February 20th, 2025 | Sandrock Alfred | director, officer: President and CEO | 296,816 | S-Sale | D | 11,702 | 4.24 USD | 49,617 USD |
| Friday, February 21st, 2025 | Sandrock Alfred | director, officer: President and CEO | 290,000 | A-Award | A | 290,000 | 4.22 USD | 1,223,800 USD |
| Friday, February 21st, 2025 | Swartz Robin | officer: COO & CBO | 169,647 | A-Award | A | 71,250 | 0.00 USD | 0 USD |
| Friday, February 21st, 2025 | Swartz Robin | officer: COO & CBO | 142,500 | A-Award | A | 142,500 | 4.22 USD | 601,350 USD |
| Thursday, February 20th, 2025 | Swartz Robin | officer: COO & CBO | 98,397 | S-Sale | D | 3,894 | 4.25 USD | 16,550 USD |
| Friday, February 21st, 2025 | Fahey Sandell Jacquelyn | officer: Chief Legal Officer | 123,143 | A-Award | A | 41,500 | 0.00 USD | 0 USD |
| Friday, February 21st, 2025 | Fahey Sandell Jacquelyn | officer: Chief Legal Officer | 83,000 | A-Award | A | 83,000 | 4.22 USD | 350,260 USD |
| Friday, February 21st, 2025 | Ferguson Toby | officer: Chief Medical Officer | 168,000 | A-Award | A | 63,000 | 0.00 USD | 0 USD |
| Friday, February 21st, 2025 | Ferguson Toby | officer: Chief Medical Officer | 126,000 | A-Award | A | 126,000 | 4.22 USD | 531,720 USD |
| Friday, February 21st, 2025 | Jorgensen Nathan D. | officer: Chief Financial Officer | 131,500 | A-Award | A | 51,500 | 0.00 USD | 0 USD |
| Friday, February 21st, 2025 | Jorgensen Nathan D. | officer: Chief Financial Officer | 103,000 | A-Award | A | 103,000 | 4.22 USD | 434,660 USD |
| Tuesday, February 11th, 2025 | Carter Todd Alfred | officer: Chief Scientific Officer | 81,023 | S-Sale | D | 5,413 | 4.45 USD | 24,088 USD |
| Tuesday, February 11th, 2025 | Swartz Robin | officer: COO & CBO | 102,291 | S-Sale | D | 6,950 | 4.45 USD | 30,928 USD |
| Tuesday, February 11th, 2025 | Sandrock Alfred | officer: President & CEO | 308,518 | S-Sale | D | 16,644 | 4.45 USD | 74,066 USD |
| Tuesday, February 11th, 2025 | Fahey Sandell Jacquelyn | officer: Chief Legal Officer | 81,643 | S-Sale | D | 4,358 | 4.45 USD | 19,393 USD |
| Tuesday, January 14th, 2025 | Swartz Robin | officer: COO & CBO | 109,241 | S-Sale | D | 3,087 | 5.09 USD | 15,713 USD |
| Tuesday, January 14th, 2025 | Carter Todd Alfred | officer: Chief Scientific Officer | 86,436 | S-Sale | D | 1,191 | 5.13 USD | 6,110 USD |
| Monday, December 23rd, 2024 | Swartz Robin | officer: COO&CBO | 112,328 | S-Sale | D | 6,500 | 5.65 USD | 36,725 USD |
| Wednesday, October 2nd, 2024 | Fahey Sandell Jacquelyn | officer: Chief Legal Officer | 86,001 | S-Sale | D | 5,999 | 5.82 USD | 34,914 USD |
| Tuesday, October 1st, 2024 | Jorgensen Nathan D. | officer: Chief Financial Officer | 80,000 | A-Award | A | 80,000 | 0.00 USD | 0 USD |
| Monday, July 8th, 2024 | Jorgensen Nathan D. | officer: Chief Financial Officer | 200,000 | A-Award | A | 200,000 | 7.79 USD | 1,558,000 USD |
| Monday, July 8th, 2024 | Jorgensen Nathan D. | officer | 0 | 0 | 0.00 USD | 0 USD | ||
| Wednesday, June 5th, 2024 | Vitale Nancy | director | 24,000 | A-Award | A | 24,000 | 8.70 USD | 208,800 USD |
| Wednesday, June 5th, 2024 | SCANGOS GEORGE A | director | 24,000 | A-Award | A | 24,000 | 8.70 USD | 208,800 USD |
| Wednesday, June 5th, 2024 | PIERCE GLENN | director | 24,000 | A-Award | A | 24,000 | 8.70 USD | 208,800 USD |
| Wednesday, June 5th, 2024 | Onyia Jude | director | 24,000 | A-Award | A | 24,000 | 8.70 USD | 208,800 USD |
| Wednesday, June 5th, 2024 | MACKEY CATHERINE J | director | 24,000 | A-Award | A | 24,000 | 8.70 USD | 208,800 USD |
| Wednesday, June 5th, 2024 | Hyman Steven | director | 24,000 | A-Award | A | 24,000 | 8.70 USD | 208,800 USD |
| Wednesday, June 5th, 2024 | Higgins Michael J | director | 24,000 | A-Award | A | 24,000 | 8.70 USD | 208,800 USD |
| Wednesday, June 5th, 2024 | GERAGHTY JAMES A | director | 24,000 | A-Award | A | 24,000 | 8.70 USD | 208,800 USD |
| Wednesday, June 5th, 2024 | Colon Grace | director | 24,000 | A-Award | A | 24,000 | 8.70 USD | 208,800 USD |
| Monday, April 1st, 2024 | Ferguson Toby | officer: Chief Medical Officer | 105,000 | A-Award | A | 105,000 | 0.00 USD | 0 USD |
| Tuesday, April 2nd, 2024 | Swartz Robin | officer: Chief Operating Officer | 117,004 | S-Sale | D | 1,357 | 9.88 USD | 13,407 USD |
| Tuesday, April 2nd, 2024 | Sandrock Alfred | director, officer: President and CEO | 322,839 | S-Sale | D | 12,115 | 9.86 USD | 119,454 USD |
| Monday, March 25th, 2024 | Ferguson Toby | officer: Chief Medical Officer | 210,000 | A-Award | A | 210,000 | 9.26 USD | 1,944,600 USD |
| Monday, March 25th, 2024 | Ferguson Toby | officer | 0 | 0 | 0.00 USD | 0 USD | ||
| Wednesday, February 21st, 2024 | Swartz Robin | officer: Chief Operating Officer | 118,361 | S-Sale | D | 3,966 | 7.45 USD | 29,547 USD |
| Wednesday, February 21st, 2024 | Sandrock Alfred | director, officer: President and CEO | 334,954 | S-Sale | D | 13,033 | 7.46 USD | 97,226 USD |
| Wednesday, February 21st, 2024 | PFREUNDSCHUH PETER P. | officer: Chief Financial Officer | 175,669 | S-Sale | D | 3,764 | 7.46 USD | 28,079 USD |
| Tuesday, February 20th, 2024 | Carter Todd Alfred | officer: Chief Scientific Officer | 90,992 | S-Sale | D | 602 | 7.68 USD | 4,623 USD |
| Wednesday, February 21st, 2024 | Carter Todd Alfred | officer: Chief Scientific Officer | 87,627 | S-Sale | D | 3,365 | 7.47 USD | 25,137 USD |
| Friday, February 9th, 2024 | Fahey Sandell Jacquelyn | officer: Chief Legal Officer | 92,000 | A-Award | A | 31,000 | 0.00 USD | 0 USD |
| Friday, February 9th, 2024 | Fahey Sandell Jacquelyn | officer: Chief Legal Officer | 62,000 | A-Award | A | 62,000 | 7.60 USD | 471,200 USD |
| Friday, February 9th, 2024 | Carter Todd Alfred | officer: Chief Scientific Officer | 91,594 | A-Award | A | 38,500 | 0.00 USD | 0 USD |
| Friday, February 9th, 2024 | Carter Todd Alfred | officer: Chief Scientific Officer | 77,000 | A-Award | A | 77,000 | 7.60 USD | 585,200 USD |
| Friday, February 9th, 2024 | Swartz Robin | officer: Chief Operating Officer | 122,327 | A-Award | A | 50,000 | 0.00 USD | 0 USD |
| Friday, February 9th, 2024 | Swartz Robin | officer: Chief Operating Officer | 100,000 | A-Award | A | 100,000 | 7.60 USD | 760,000 USD |
| Friday, February 9th, 2024 | Sandrock Alfred | director, officer: President and CEO | 347,987 | A-Award | A | 130,000 | 0.00 USD | 0 USD |
| Friday, February 9th, 2024 | Sandrock Alfred | director, officer: President and CEO | 260,000 | A-Award | A | 260,000 | 7.60 USD | 1,976,000 USD |
| Friday, February 9th, 2024 | PFREUNDSCHUH PETER P. | officer: Chief Financial Officer | 179,433 | A-Award | A | 30,000 | 0.00 USD | 0 USD |
| Friday, February 9th, 2024 | PFREUNDSCHUH PETER P. | officer: Chief Financial Officer | 60,000 | A-Award | A | 60,000 | 7.60 USD | 456,000 USD |
| Wednesday, January 17th, 2024 | Swartz Robin | officer: Chief Operating Officer | 72,327 | S-Sale | D | 2,543 | 7.15 USD | 18,183 USD |
| Wednesday, January 17th, 2024 | Carter Todd Alfred | officer: Chief Scientific Officer | 53,094 | S-Sale | D | 1,266 | 7.18 USD | 9,090 USD |
| Tuesday, October 3rd, 2023 | PFREUNDSCHUH PETER P. | officer: Chief Financial Officer | 149,433 | S-Sale | D | 13,567 | 6.99 USD | 94,833 USD |
| Sunday, October 1st, 2023 | Fahey Sandell Jacquelyn | officer: Chief Legal Officer | 61,000 | A-Award | A | 61,000 | 0.00 USD | 0 USD |
| Friday, September 15th, 2023 | Carter Todd Alfred | officer: Chief Scientific Officer | 64,860 | M-Exempt | A | 5,000 | 2.85 USD | 14,250 USD |
| Friday, September 15th, 2023 | Carter Todd Alfred | officer: Chief Scientific Officer | 54,360 | S-Sale | D | 10,500 | 8.16 USD | 85,680 USD |
| Friday, September 15th, 2023 | Carter Todd Alfred | officer: Chief Scientific Officer | 40,000 | M-Exempt | D | 5,000 | 2.85 USD | 14,250 USD |
| Monday, July 10th, 2023 | Fahey Sandell Jacquelyn | officer: Chief Legal Officer | 122,000 | A-Award | A | 122,000 | 10.18 USD | 1,241,960 USD |
| Monday, July 10th, 2023 | Fahey Sandell Jacquelyn | officer | 0 | 0 | 0.00 USD | 0 USD | ||
| Thursday, July 6th, 2023 | Carter Todd Alfred | officer: Chief Scientific Officer | 59,860 | S-Sale | D | 5,500 | 10.80 USD | 59,400 USD |
| Friday, June 30th, 2023 | Carter Todd Alfred | officer: Chief Scientific Officer | 70,360 | M-Exempt | A | 5,000 | 2.85 USD | 14,250 USD |
| Friday, June 30th, 2023 | Carter Todd Alfred | officer: Chief Scientific Officer | 65,360 | S-Sale | D | 5,000 | 11.41 USD | 57,050 USD |
| Friday, June 30th, 2023 | Carter Todd Alfred | officer: Chief Scientific Officer | 45,000 | M-Exempt | D | 5,000 | 2.85 USD | 14,250 USD |
| Tuesday, June 6th, 2023 | PIERCE GLENN | director | 22,000 | A-Award | A | 22,000 | 12.57 USD | 276,540 USD |
| Tuesday, June 6th, 2023 | MACKEY CATHERINE J | director | 22,000 | A-Award | A | 22,000 | 12.57 USD | 276,540 USD |
| Tuesday, June 6th, 2023 | Vitale Nancy | director | 22,000 | A-Award | A | 22,000 | 12.57 USD | 276,540 USD |
| Tuesday, June 6th, 2023 | Onyia Jude | director | 22,000 | A-Award | A | 22,000 | 12.57 USD | 276,540 USD |
| Tuesday, June 6th, 2023 | Higgins Michael J | director | 22,000 | A-Award | A | 22,000 | 12.57 USD | 276,540 USD |
| Tuesday, June 6th, 2023 | Colon Grace | director | 22,000 | A-Award | A | 22,000 | 12.57 USD | 276,540 USD |
| Tuesday, June 6th, 2023 | GERAGHTY JAMES A | director | 22,000 | A-Award | A | 22,000 | 12.57 USD | 276,540 USD |
| Tuesday, June 6th, 2023 | SCANGOS GEORGE A | director | 22,000 | A-Award | A | 22,000 | 12.57 USD | 276,540 USD |
| Tuesday, June 6th, 2023 | Hyman Steven | director | 22,000 | A-Award | A | 22,000 | 12.57 USD | 276,540 USD |
| Tuesday, May 9th, 2023 | SCANGOS GEORGE A | director | 44,000 | A-Award | A | 44,000 | 10.76 USD | 473,440 USD |
| Tuesday, May 9th, 2023 | SCANGOS GEORGE A | director: | 0 | 0 | 0.00 USD | 0 USD | ||
| Monday, April 3rd, 2023 | Sandrock Alfred | director, officer: President and CEO | 214,618 | S-Sale | D | 7,437 | 7.83 USD | 58,232 USD |
| Monday, April 3rd, 2023 | Swartz Robin | officer: Chief Operating Officer | 71,617 | S-Sale | D | 1,259 | 7.83 USD | 9,858 USD |
| Wednesday, March 15th, 2023 | Swartz Robin | officer: Chief Operating Officer | 76,530 | S-Sale | D | 15,373 | 8.20 USD | 126,059 USD |
| Thursday, February 23rd, 2023 | Onyia Jude | director | 44,000 | A-Award | A | 44,000 | 6.92 USD | 304,480 USD |
| Thursday, February 23rd, 2023 | Onyia Jude | director | 2,910 | D | 0 | 0.00 USD | 0 USD | |
| Thursday, February 23rd, 2023 | NEUROCRINE BIOSCIENCES INC | 10 percent owner | 8,575,316 | P-Purchase | A | 4,395,588 | 8.88 USD | 39,032,821 USD |
| Friday, February 17th, 2023 | Hesslein Robert W. | officer: Senior VP & General Counsel | 106,610 | S-Sale | D | 3,297 | 7.45 USD | 24,563 USD |
| Friday, February 17th, 2023 | Carter Todd Alfred | officer: Chief Scientific Officer | 68,291 | A-Award | A | 34,000 | 0.00 USD | 0 USD |
| Friday, February 17th, 2023 | Carter Todd Alfred | officer: Chief Scientific Officer | 68,000 | A-Award | A | 68,000 | 7.43 USD | 505,240 USD |
| Friday, February 17th, 2023 | Carter Todd Alfred | officer: Chief Scientific Officer | 67,553 | S-Sale | D | 738 | 7.45 USD | 5,498 USD |
